Case Report: A Case Report and Literature Review on Severe Bullous Skin Reaction Induced by anti-PD-1 Immunotherapy in a Cervical Cancer Patient

Background: Anti-programmed cell death protein 1 (PD-1) has been successfully used in carcinomas treatment. However, it causes significant adverse effects (AEs), including cutaneous reactions, particularly the life-threatening severe bullous skin reactions (SBSR) and toxic epidermal necrolysis (TEN)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiang, Qu, Li-Xin, Ren, Yu-Mei, Hu, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423354/
https://www.ncbi.nlm.nih.gov/pubmed/34504425
http://dx.doi.org/10.3389/fphar.2021.707967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423354/
https://www.ncbi.nlm.nih.gov/pubmed/34504425
http://dx.doi.org/10.3389/fphar.2021.707967

Ejemplares similares